Meanwhile at the TCT there have been very dismal results for Boston scientific with their TAVR/TMVR that could present an opportunity for Anteris, perhaps a partnership or a Tissue supply deal, as their TAVR/TMVR dreams have taken a huge setback and will need better tissue and design to stay in the race, anyways here is the podcast:
https://medtech.pharmaintelligence.informa.com/MT142956/Device-Week-23-October-2020--Conference-Spotlight-TCT-HLTH
in case any of you have issues with the link above I have downloaded the mp3 to the link below:
https://mega.nz/file/P80ynBSD#is3R2MukD58_FXVMrIZm16TUY0MT6K9yTennm4FSDwA
thoughts?
Meanwhile at the TCT there have been very dismal results for...
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.55 |
Change
0.000(0.00%) |
Mkt cap ! $356.5M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 204 | $18.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.90 | 500 | 1 |
View Market Depth
| Last trade - 10.10am 28/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |
Day chart unavailable